HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma].

AbstractBACKGROUND/AIM:
Cytokeratins (CK) 5/6 and 17, myoepithelial markers, are also expressed in a proportion of breast carcinomas. Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that shows common but heterogeneous morphological, genetical, and immunophenotypical features and is associated with poor clinical outcome. The aim of this study was to determine the incidence of basal expression of cytokines CK5/6 and CK17 in the tested samples of ductal invasive breast cancers, as well as to test the presence of a correlation of tumor expression of basal cytokines and clinicopathological prognostic factors: age, the level of histological differentiation, hormone receptor status, HER2 (human epidermal growth factor receptor 2) protein expresion and HER2 gene amplification in tumorous tissue.
METHODS:
Immunohistochemistry (IHC) was used to evaluate the CK5/6 and CK17 status of 121 ductal invasive breast cancers. The results thus obtained were compared with clinicopathological characteristics.
RESULTS:
From the 117 analyzed tumor specimens, 22% and 30% were immunohistochemically positive for CK5/6 and CK17, respectively. Basal cytokeratins showed significant inverse relationship with estrogen and progesterone receptor status and HER2 protein expression. CK5/6 and CK17 immunoreactivities were directly associated with triple-negative phenotype and higher histological grade.
CONCLUSION:
Our findings are similar to reports that tumours expression of basal cytokeratins are correlated with adverse pathological parameters. Given the limited number of emerging therapeutic targets in these tumors, routine IHC identification of basal-like subtype as a poor prognostic group of breast cancer could be based on the expression of basal CKs.
AuthorsTatjana Ivković-Kapicl, Milana Panjković, Ivan Nikolić, Dragana Djilas-Ivanović, Slavica Knezević-Usaj
JournalVojnosanitetski pregled (Vojnosanit Pregl) Vol. 69 Issue 12 Pg. 1031-8 (Dec 2012) ISSN: 0042-8450 [Print] Serbia
PMID23424955 (Publication Type: Journal Article)
Chemical References
  • Keratin-17
  • Keratin-5
  • Keratin-6
Topics
  • Breast Neoplasms (metabolism)
  • Carcinoma, Ductal, Breast (metabolism)
  • Female
  • Humans
  • Keratin-17 (metabolism)
  • Keratin-5 (metabolism)
  • Keratin-6 (metabolism)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: